From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.69
First Reported 2005
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 3
Total Number 3
Disease Relevance 2.89
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

signal transduction (KRAS) mitochondrion (KRAS) plasma membrane (KRAS)
GTPase activity (KRAS)
Anatomy Link Frequency
lung 1
KRAS (Homo sapiens)
Pain Link Frequency Relevance Heat
antagonist 2 30.08 Quite Low
Bile 6 5.00 Very Low Very Low Very Low
palliative 4 5.00 Very Low Very Low Very Low
metalloproteinase 1 5.00 Very Low Very Low Very Low
pain pelvic 1 5.00 Very Low Very Low Very Low
Inflammation 1 5.00 Very Low Very Low Very Low
Pain 1 5.00 Very Low Very Low Very Low
imagery 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Cancer 138 99.64 Very High Very High Very High
Cholangiocarcinoma 74 99.12 Very High Very High Very High
Endometrial Cancer 153 95.68 Very High Very High Very High
Adenocarcinoma 20 91.32 High High
Carcinoma 67 81.20 Quite High
Nicotine Addiction 1 78.08 Quite High
Colorectal Cancer 9 74.24 Quite High
Carcinosarcoma 29 73.28 Quite High
Sarcoma 24 57.04 Quite High
Disease 11 50.48 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Interestingly, EGFR and KRAS mutations are rarely found in the same tumors, suggesting that they have functionally equivalent roles in lung tumorigenesis ([8]; M.
Localization (found) of KRAS in lung associated with cancer
1) Confidence 0.69 Published 2005 Journal PLoS Medicine Section Body Doc Link PMC545207 Disease Relevance 0.56 Pain Relevance 0
They are associated with a number of well-described genetic alterations including mutations of PTEN, KRAS, ?
Localization (mutations) of KRAS
2) Confidence 0.60 Published 2010 Journal Obstetrics and Gynecology International Section Body Doc Link PMC2846683 Disease Relevance 1.23 Pain Relevance 0
One of them is that KRAS mutations should be examined in the clinical trials on the effect of EGFR blockade in this tumor type.
Localization (blockade) of KRAS associated with cancer
3) Confidence 0.55 Published 2010 Journal BMC Cancer Section Body Doc Link PMC2896958 Disease Relevance 1.10 Pain Relevance 0

General Comments

This test has worked.

Personal tools